A critical appraisal of the harm reduction argument for heat-not-burn tobacco products

Heat-not-burn products (HNBs) are efficient nicotine delivery devices that heat tobacco instead of burning it, as conventional cigarettes do. Since heating yields less carbon monoxide and other tobacco pyrolysis–derived toxicants, tobacco companies claim that HNBs are less harmful than conventional...

Full description

Bibliographic Details
Main Author: Francisco J.R. Paumgartten
Format: Article
Language:English
Published: Pan American Health Organization 2018-12-01
Series:Revista Panamericana de Salud Pública
Subjects:
Online Access:http://iris.paho.org/xmlui/handle/123456789/49697
id doaj-2fe3119ef02949df901307c0f4124f47
record_format Article
spelling doaj-2fe3119ef02949df901307c0f4124f472020-11-25T00:03:38ZengPan American Health OrganizationRevista Panamericana de Salud Pública1020-49891680-53482018-12-01421610.26633/RPSP.2018.161e161A critical appraisal of the harm reduction argument for heat-not-burn tobacco productsFrancisco J.R. Paumgartten0The National School of Public Health, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Rio de Janeiro, BrazilHeat-not-burn products (HNBs) are efficient nicotine delivery devices that heat tobacco instead of burning it, as conventional cigarettes do. Since heating yields less carbon monoxide and other tobacco pyrolysis–derived toxicants, tobacco companies claim that HNBs are less harmful than conventional cigarettes are. Although this hypothesis is plausible, no long-term clinical trials and/or observational studies are available to corroborate it. To overcome barriers to the entry of tobacco products to the market, manufacturers of HNBs argue that they are a new wave of harm reduction alternatives. Nonetheless, even if HNBs were in fact less harmful than conventional cigarettes, they would still have the potential to cause nicotine addiction (a major health hazard) and other harms to smokers’ health. HNBs deliver nicotine, provide users a tobacco aroma and flavor and some rituals of smoking, and are supposedly safer than conventional cigarettes. Owing to these features, HNBs are likely to enhance smoking appeal and initiation among young persons and discourage smokers’ attempts to quit. In other words, if HNBs were freely available on the market, they would increase the prevalence of smoking. However, HNBs may constitute a harm reduction alternative for nicotine-dependent smokers who are unable or unwilling to quit smoking. Given these facts, approval of HNBs for use under medical supervision (prescription only), along with strict restrictions on advertising, is a balanced regulatory option that would reconcile the therapeutic needs of nicotine-addicted patients with the public heath goal of achieving a smoke-free generation in the near future.http://iris.paho.org/xmlui/handle/123456789/49697Tobacco use disorderneoplasmsharm reductionnicotinesmoking
collection DOAJ
language English
format Article
sources DOAJ
author Francisco J.R. Paumgartten
spellingShingle Francisco J.R. Paumgartten
A critical appraisal of the harm reduction argument for heat-not-burn tobacco products
Revista Panamericana de Salud Pública
Tobacco use disorder
neoplasms
harm reduction
nicotine
smoking
author_facet Francisco J.R. Paumgartten
author_sort Francisco J.R. Paumgartten
title A critical appraisal of the harm reduction argument for heat-not-burn tobacco products
title_short A critical appraisal of the harm reduction argument for heat-not-burn tobacco products
title_full A critical appraisal of the harm reduction argument for heat-not-burn tobacco products
title_fullStr A critical appraisal of the harm reduction argument for heat-not-burn tobacco products
title_full_unstemmed A critical appraisal of the harm reduction argument for heat-not-burn tobacco products
title_sort critical appraisal of the harm reduction argument for heat-not-burn tobacco products
publisher Pan American Health Organization
series Revista Panamericana de Salud Pública
issn 1020-4989
1680-5348
publishDate 2018-12-01
description Heat-not-burn products (HNBs) are efficient nicotine delivery devices that heat tobacco instead of burning it, as conventional cigarettes do. Since heating yields less carbon monoxide and other tobacco pyrolysis–derived toxicants, tobacco companies claim that HNBs are less harmful than conventional cigarettes are. Although this hypothesis is plausible, no long-term clinical trials and/or observational studies are available to corroborate it. To overcome barriers to the entry of tobacco products to the market, manufacturers of HNBs argue that they are a new wave of harm reduction alternatives. Nonetheless, even if HNBs were in fact less harmful than conventional cigarettes, they would still have the potential to cause nicotine addiction (a major health hazard) and other harms to smokers’ health. HNBs deliver nicotine, provide users a tobacco aroma and flavor and some rituals of smoking, and are supposedly safer than conventional cigarettes. Owing to these features, HNBs are likely to enhance smoking appeal and initiation among young persons and discourage smokers’ attempts to quit. In other words, if HNBs were freely available on the market, they would increase the prevalence of smoking. However, HNBs may constitute a harm reduction alternative for nicotine-dependent smokers who are unable or unwilling to quit smoking. Given these facts, approval of HNBs for use under medical supervision (prescription only), along with strict restrictions on advertising, is a balanced regulatory option that would reconcile the therapeutic needs of nicotine-addicted patients with the public heath goal of achieving a smoke-free generation in the near future.
topic Tobacco use disorder
neoplasms
harm reduction
nicotine
smoking
url http://iris.paho.org/xmlui/handle/123456789/49697
work_keys_str_mv AT franciscojrpaumgartten acriticalappraisaloftheharmreductionargumentforheatnotburntobaccoproducts
AT franciscojrpaumgartten criticalappraisaloftheharmreductionargumentforheatnotburntobaccoproducts
_version_ 1725432779241422848